Rhea-AI Summary
Iterum Therapeutics plc notified Nasdaq of the removal of its Ordinary Shares from listing and/or registration on the Nasdaq Stock Market LLC pursuant to Form 25 and the cited rules 17 CFR 240.12d2-2. The Exchange certified compliance with its procedures for withdrawal.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many Iterum Therapeutics plc (ITRMF) SEC filings are available on StockTitan?
StockTitan tracks 1 SEC filings for Iterum Therapeutics plc (ITRMF), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Iterum Therapeutics plc (ITRMF)?
The most recent SEC filing for Iterum Therapeutics plc (ITRMF) was filed on June 23, 2026.